רנקסה 1000 מ"ג

Země: Izrael

Jazyk: hebrejština

Zdroj: Ministry of Health

Aktivní složka:

RANOLAZINE 1000 MG

Dostupné s:

NEOPHARM LTD

ATC kód:

C01EB18

Léková forma:

TABLETS EXTENDED RELEASE

Podání:

PER OS

Výrobce:

CV THERAPEUTICS INC, USA

Terapeutické skupiny:

RANOLAZINE

Terapeutické indikace:

Ranexa is indicated for the treatment of chronic angina. Ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).Ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers.

Datum autorizace:

2010-10-01